Literature DB >> 17621242

Association of general and abdominal obesities and metabolic syndrome with subclinical atherosclerosis in asymptomatic Chinese postmenopausal women.

Ruby H Y Yu1, Suzanne C Ho, Stella S Y Ho, Jean L F Woo, A T Ahuja.   

Abstract

OBJECTIVE: This study aimed to investigate the relationships between obesity, especially abdominal obesity, andmetabolic syndrome (MS) with carotid intima-media thickness (IMT) and plaque, markers of subclinical atherosclerosis, in asymptomatic Chinese postmenopausal women in Hong Kong.
DESIGN: A total of 518 postmenopausal women aged 50 to 64 years were recruited through random telephone dialing. Body mass index (BMI), waist circumference, waist-to-hip ratio, sociodemographic characteristics, blood pressures, medical, biochemical and lifestyle factors were obtained. MS was defined on the basis of the National Cholesterol and Education Program, Adult Treatment Panel III criteria. Subclinical atherosclerosis was determined by measuring IMT and plaque using high-resolution B-mode ultrasonography.
RESULTS: Women with a BMI of 25 kg/mor greater, a waist circumference of 80 cm or greater, a waist-to-hip ratio of 0.85 or greater, or MS were observed to have higher IMT values and prevalence of plaque. Multivariate analyses revealed that waist circumference was significantly associated with IMT independent of age, hormone therapy, lifestyle and sociodemographic factors, and BMI (P < 0.05), whereas a waist-to-hip ratio of 0.85 or greater was significantly associated with plaque (odds ratio = 1.7; 95% CI: 1.0-2.8) after controlling for age, hormone therapy, lifestyle and sociodemographic factors, BMI, and the traditional cardiovascular risk factors. MS was also associated with IMT after adjustment for age, hormone therapy, lifestyle and sociodemographic factors, and BMI (P < 0.05), whereas its association with plaque was also significant (odds ratio = 1.7; 95% CI: 1.0-2.6) after controlling for age.
CONCLUSIONS: Abdominal obesity and MS are independent of general obesity markers of subclinical atherosclerosis in Chinese postmenopausal women.

Entities:  

Mesh:

Year:  2008        PMID: 17621242     DOI: 10.1097/gme.0b013e31806458c9

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  6 in total

1.  Contribution of visceral fat accumulation to carotid intima-media thickness in a Chinese population.

Authors:  Y Wang; X Ma; M Zhou; W Zong; L Zhang; Y Hao; J Zhu; Y Xiao; D Li; Y Bao; W Jia
Journal:  Int J Obes (Lond)       Date:  2011-11-29       Impact factor: 5.095

2.  Reappraisal of waist circumference cutoff value according to general obesity.

Authors:  Kyung-Soo Kim; Hyun-Ju Oh; Young Ju Choi; Byung Wook Huh; Soo-Kyung Kim; Seok Won Park; Eun Jig Lee; Yong-Wook Cho; Kap-Bum Huh
Journal:  Nutr Metab (Lond)       Date:  2016-04-05       Impact factor: 4.169

3.  Obesity, arterial function and arterial structure - a systematic review and meta-analysis.

Authors:  J Y A Ne; T Y Cai; D S Celermajer; I D Caterson; T Gill; C M Y Lee; M R Skilton
Journal:  Obes Sci Pract       Date:  2017-04-27

4.  Are Obesity Indices Useful for Detecting Subclinical Atheromatosis in a Middle-Aged Population?

Authors:  Enric Sánchez; Marta Sánchez; Àngels Betriu; Ferran Rius; Gerard Torres; Francesc Purroy; Reinald Pamplona; Marta Ortega; Carolina López-Cano; Marta Hernández; Marta Bueno; Elvira Fernández; Javier Salvador; Albert Lecube
Journal:  Obes Facts       Date:  2020-01-22       Impact factor: 4.807

5.  Association of simple anthropometric indices and body fat with early atherosclerosis and lipid profiles in Chinese adults.

Authors:  Zhe-qing Zhang; Li-ping He; Xiao-yan Xie; Wen-hua Ling; Juan Deng; Yi-xiang Su; Yu-ming Chen
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

6.  Association between waist-hip ratio and coronary artery calcification in postmenopausal women.

Authors:  Youngmi Eun; Su Nam Lee; Jin Jung; Min Sik Kim; Keon-Woong Moon; Ki-Dong Yoo
Journal:  Menopause       Date:  2020-09       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.